Tissue eosinophilia in relation to immunopathological and clinical characteristics in Hodgkin's disease

Leukemia and Lymphoma

Volumn 42, Issue 5, 2001, Pages 1055-1065

  Axdorph, U ^a   Porwit Macdonald, ^a   Grimfors, G ^a   Bjorkholm M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CD3 chain; Eosinophilia; Granzyme B; Hodgkin's disease; T cells; TIA 1

Indexed keywords

CD3 ANTIGEN; CD57 ANTIGEN; CD8 ANTIGEN; CELL PROTEIN; GRANZYME B; HLA DR ANTIGEN; LATENT MEMBRANE PROTEIN 1; T LYMPHOCYTE ANTIGEN;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; CELL COUNT; CELL SIZE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC VALUE; EOSINOPHILIA; FEMALE; GENDER; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; LYMPHOCYTE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REED STERNBERG CELL; SCLEROSIS;

EID: 0034839397     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190109097726     Document Type: Article

References (47)

1. Selective peripheral blood eosinophilia associated with survival advantage in Hodgkin's disease (BNLI Report No 31)
2. Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia
3. Blood eosinophilia in Hodgkin's disease. A follow-up of 25 cases in Venezuela
4. Infiltration of eosinophils in Hodgkin's disease involved lymph nodes predicts prognosis
5. Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors
6. Eosinophilia
7. Hodgkin/Reed-Sternberg cells induce fibroblasts to secrete eotaxin, a potent chemoattractant for T cells and eosinophils
8. Immune reactions in classical Hodgkin's lymphoma
9. Relationship between eosinophil density and T-cell activation markers in lymph nodes of patients with Hodgkin's Disease
10. Human eosinophils regulate human lung- and skin-derived fibroblast properties in vitro: A role for transforming growth factor beta (TGF-β)
11. Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease
12. Eosinophils are the major source of transforming growth factor-β 1 in nodular sclerosing Hodgkin's disease
13. Transforming growth factor (β1) messenger RNA in Reed-Sternberg cells in nodular sclerosing Hodgkin's disease
14. Transforming growth factor-β, an important mediator of immunoregulation
15. Lymphocyte function in untreated Hodgkin's disease: An important predictor of prognosis
16. The role of eosinophils in the pathobiology of Hodgkin's disease
17. Hodgkin's disease, a clinicopathologic study of 659 cases
18. Lack of prognostic value of histopathologic parameters in Hodgkin's disease, nodular sclerosis type
19. Hodgkin disease in patients 60 years of age or older. Histologic and clinical features of advanced-stage disease
20. Histopathologic grading of nodular sclerosis Hodgkin's disease
21. Epstein-Barr virus expression in Hodgkin's disease in relation to patient characteristics, serum factors and blood lymphocyte function
22. Report of the Committee on Hodgkin's disease staging classification
23. Prognostic factors in Hodgkin's disease. II. The role of lymphocyte defect
24. Fixed versus response adapted MOPP/ABVD chemotherapy in Hodgkin's disease
25. Prognostic influence of early diagnostic splenectomy in Hodgkin's disease. A long-term follow-up
26. Increased serum CD 8 soluble antigen level is associated with blood lymphocyte abnormalities and other established indicators of poor prognosis in adult Hodgkin's disease
27. A revised European-American classification of lymphoid neoplasms. A proposal from the international lymphoma study group
28. Relationship of histopathologic features to survival and relapse in nodular sclerosing Hodgkin's disease
29. Inter-rater Agreement
30. Tumor cell concentration and tumor burden in relation to histopathologic subtype and other prognostic factors in early stage Hodgkin's disease
31. DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas
32. Lymphocyte abnormalities in untreated patients with Hodgkin's disease
33. Exact significance testing to establish treatment equivalence for ordered categorial data
34. Nonparametric estimation from incomplete observations
35. A generalised Wilcoxon test for comparing arbitrarily single-censored samples
36. IgE, Reed-Sternberg cells, and eosinophilia in Hodgkin's disease
37. Eosinophil peroxidase is detectable with a monoclonal antibody in collagen bands of nodular sclerosis Hodgkin's disease
38. Differential chemokine expression in tissues involved by Hodgkin's disease: Direct correlation of eotaxin expression and tissue eosinophilia
39. The role of chemokines in Hodgkin's disease
40. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltrate in Hodgkin's lymphoma
41. Analysis of major histocompatibility complex class I expression on Reed-Sternberg cells in relation to the cytotoxic T-cell response in Epstein-Barr virus-positive and -negative Hodgkin's disease
42. Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive and -negative cases of Hodgkin's disease
43. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease
44. Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease
45. All infiltrating T-lymphocytes in Hodgkin's disease express immunohistochemically detectable T-cell receptor ζ-chains in situ